First, FOXO3 expression could affect AD development directly, perhaps via effects on apoptosis in neurons or genetic buffering of APOE or other loci.35,36 Second, FOXO3 could affect AD risk indirectly via susceptibility to other diseases (i.e., competing risks of death) occurring earlier in the life course. The gene discussed is APOE; the disease is Alzheimer disease.